Dr. Lal PathLabs fell 2.34% to Rs 2081.30 after the company reported 56.8% drop in consolidated net profit to Rs 57.7 crore on a 17.1% fall in revenue from operations to Rs 502.7 crore in Q1 FY23 over Q1 FY22.
Profit before tax in Q1 FY23 stood at Rs 81.4 crore, down by 54.6% from Rs 179.3 crore in Q1 FY22.
Expenditure declined by 7.8% to Rs 385.2 crore in Q1 FY23 over Q1 FY22.
EBITDA fell by 37.8% to Rs 117.5 crore in Q1 FY23 from Rs 189 crore in Q1 FY22. EBITDA margin in Q1 FY23 was 23.4% as against 31.2% in Q1 FY22.
Net cash and cash equivalents was at Rs 436 crore as on 30 June 2022.
Dr. Om Manchanda, managing director, said: In the long run the market share transfer from the unorganized to the organized sector will accelerate due to a change in industry patterns.
We continue to focus on expanding our reach, bringing innovation and execution focus in our services. Further with the reversion to pre-pandemic growth, there is room for inorganic expansion and we are wholly geared to utilize our service quality and network effect to enhance our operating footprint.''
Bharath Uppiliappan, chief executive officer, stated: In the non-covid business, we realized 24.9% of growth Q-o-Q basis. We continue to drive programs around South geography, Swasthfit and Super Specialty.
As leaders in diagnostic industry we have taken upon the task of establishing India's first center of excellence for Autoimmunity L-ACE. This initiative combined with our focus on genomics to further strengthen our position in Super Specialty
Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. As on March 31, 2022 the company has 277 clinical laboratories, 4,731 Patient Service Centers (PSCs) and 10,599 Pick-up Points (PUPs).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app